1.
Ayuk F, Perez-Simon JA, Shimoni A, Sureda A, Zabelina T, Schwerdtfeger R, Martino R, Sayer HG, Alegre A, Lahuerta J-J, Atanackovic D, Wolschke C, Nagler A, Zander AR, San Miguel JF, Kröger N. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation. Haematologica [Internet]. 2008Aug.29 [cited 2026Nov.16];93(9):1343-50. Available from: https://haematologica.org/article/view/4993